170 related articles for article (PubMed ID: 33775670)
21. Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.
Zakeri S; Afsharpad M; Ghasemi F; Raeisi A; Safi N; Butt W; Atta H; Djadid ND
Malar J; 2010 Mar; 9():75. PubMed ID: 20226087
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
[TBL] [Abstract][Full Text] [Related]
23. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.
Pearce RJ; Drakeley C; Chandramohan D; Mosha F; Roper C
Antimicrob Agents Chemother; 2003 Apr; 47(4):1347-54. PubMed ID: 12654669
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
25. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
Djaman JA; Mazabraud A; Basco L
Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
[TBL] [Abstract][Full Text] [Related]
26. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
27. Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome.
Khalil I; Alifrangis M; Rønn AM; Gabar HA; Jelinek T; Satti GM; Bygbjerg IC
Am J Trop Med Hyg; 2002 Sep; 67(3):225-9. PubMed ID: 12408659
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.
Barnadas C; Tichit M; Bouchier C; Ratsimbasoa A; Randrianasolo L; Raherinjafy R; Jahevitra M; Picot S; Ménard D
Malar J; 2008 Feb; 7():35. PubMed ID: 18302746
[TBL] [Abstract][Full Text] [Related]
29. Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa.
Zhao L; Pi L; Qin Y; Lu Y; Zeng W; Xiang Z; Qin P; Chen X; Li C; Zhang Y; Wang S; Si Y; Yang G; Rosenthal BM; Huang Y; Yang Z
Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():1-6. PubMed ID: 31809965
[TBL] [Abstract][Full Text] [Related]
30. Molecular monitoring of dihydrofolatereductase (dhfr) and dihydropteroatesynthetase (dhps) associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates of Palawan, Philippines.
Bareng AP; Espino FE; Chaijaroenkul W; Na-Bangchang K
Acta Trop; 2018 Apr; 180():81-87. PubMed ID: 29352991
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
Rakmark K; Awab GR; Duanguppama J; Boonyuen U; Dondorp AM; Imwong M
Malar J; 2020 Jul; 19(1):251. PubMed ID: 32664924
[TBL] [Abstract][Full Text] [Related]
32. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.
Kun JF; Lehman LG; Lell B; Schmidt-Ott R; Kremsner PG
Antimicrob Agents Chemother; 1999 Sep; 43(9):2205-8. PubMed ID: 10471565
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
[TBL] [Abstract][Full Text] [Related]
34. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.
Narang G; Jakhan J; Tamang S; Yadav K; Singh V
Acta Trop; 2024 Jul; 255():107218. PubMed ID: 38636585
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
[TBL] [Abstract][Full Text] [Related]
36. Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.
Oguike MC; Falade CO; Shu E; Enato IG; Watila I; Baba ES; Bruce J; Webster J; Hamade P; Meek S; Chandramohan D; Sutherland CJ; Warhurst D; Roper C
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):220-229. PubMed ID: 27821281
[TBL] [Abstract][Full Text] [Related]
37. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
Wang P; Read M; Sims PF; Hyde JE
Mol Microbiol; 1997 Mar; 23(5):979-86. PubMed ID: 9076734
[TBL] [Abstract][Full Text] [Related]
38. Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.
Asih PB; Marantina SS; Nababan R; Lobo NF; Rozi IE; Sumarto W; Dewi RM; Tuti S; Taufik AS; Mulyanto ; Sauerwein RW; Syafruddin D
Malar J; 2015 Sep; 14():365. PubMed ID: 26395428
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
[TBL] [Abstract][Full Text] [Related]
40. Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia.
Al-Farsi HM; Al-Hashami ZS; Bin Dajem SM; Al-Sheikh AA; Al-Qahtani A; Beja-Pereira A; Idris MA; Babiker HA
Infect Genet Evol; 2012 Aug; 12(6):1253-9. PubMed ID: 22709478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
